Angina

Cardiovascular·MeSH: Angina Pectoris

11 drugs in development·8 companies·1 clinical trial

Drug Pipeline by Phase

Approved(10)

Drug	Company
amlodipine	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
clopidogrel bi	DR REDDYS LABORATORIES LTD (RDY)
clopidogrel bi	Teva Pharmaceutical Industries Limited (TEVA)
isosorbide mono	EXELIXIS, INC. (EXEL)
nicardipine	Amneal Pharmaceuticals, Inc. (AMRX)
nitroglycerin	DR REDDYS LABORATORIES LTD (RDY)
prasugrel	Mylan II B.V. (MYL)
ranolazine	Amneal Pharmaceuticals, Inc. (AMRX)
VASCEPA (VAZKEPA in EU)	AMARIN CORP PLCUK (AMRN)
VASCEPA (VAZKEPA)	AMARIN CORP PLCUK (AMRN)

Phase 3(1)

Drug	Company
CardiAMP®	BioCardia, Inc. (BCDA)

BioSniper tracks 11 drugs in development for Angina across 8 companies.

There are 1 clinical trial targeting Angina tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.